ArticleOncology letters2025

Safety and efficacy outcomes of delta‑like ligand 3 inhibitors for the treatment of solid tumors: A systematic review and single‑arm meta‑analysis.

Yaxu Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.